These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16084844)

  • 1. Successful bridging strategy based on ICH E5 guideline for drugs approved in Japan.
    Uyama Y; Shibata T; Nagai N; Hanaoka H; Toyoshima S; Mori K
    Clin Pharmacol Ther; 2005 Aug; 78(2):102-13. PubMed ID: 16084844
    [No Abstract]   [Full Text] [Related]  

  • 2. Characteriation of clinical data packages using foreign data in new drug applications in Japan.
    Tanaka M; Nagata T
    Clin Pharmacol Ther; 2008 Sep; 84(3):340-6. PubMed ID: 17786162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delays in new drug applications in Japan and industrial R&D strategies.
    Hirai Y; Kinoshita H; Kusama M; Yasuda K; Sugiyama Y; Ono S
    Clin Pharmacol Ther; 2010 Feb; 87(2):212-8. PubMed ID: 19940847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Globalization of clinical trials].
    Akaza H; Fukuoka M; Ohtsu A; Usami M; Ikeda T; Aiba K; Isonishi S; Ohashi Y; Saijo N; Sone S; Tsukagoshi S; Tsuruo T; Kato M; Mikami O; Dong RP; von Euler M; Blackledge G; Stribling D
    Gan To Kagaku Ryoho; 2003 Apr; 30(4):555-65. PubMed ID: 12722692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. They are from the government and they really are here to help you.
    Woosley RL
    J Clin Pharmacol; 2008 Feb; 48(2):142-3. PubMed ID: 18199889
    [No Abstract]   [Full Text] [Related]  

  • 6. Communicating with the FDA: the "third rail" of a new model for drug development.
    Stanski DR; Orloff JJ
    J Clin Pharmacol; 2008 Feb; 48(2):144-5. PubMed ID: 18199890
    [No Abstract]   [Full Text] [Related]  

  • 7. Good clinical practice--a practical experience.
    Ogunsola FT
    Nig Q J Hosp Med; 2008; 18(2):123-4. PubMed ID: 19068567
    [No Abstract]   [Full Text] [Related]  

  • 8. Good clinical practice in clinical drug trials--what you need to know.
    Soyebi K; Abosede ; Coker HA; Osuntoki ; Oyibos W; Keri H; Ogunsola S
    Nig Q J Hosp Med; 2008; 18(2):104-12. PubMed ID: 19068563
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficient clinical trials in Japan: Bridging studies versus participation in global clinical trials.
    Shirotani M; Suwa T; Kurokawa T; Chiba K
    J Clin Pharmacol; 2014 Apr; 54(4):438-45. PubMed ID: 24165947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The revision of Guidelines for Clinical Evaluation Methods of Anti-Cancer Drugs in Japan].
    Andoh M; Fujiwara Y; Shimada Y
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):1015-9. PubMed ID: 16878363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric drug development in anesthesiology: an FDA perspective.
    Schultheis LW; Mathis LL; Roca RA; Simone AF; Hertz SH; Rappaport BA
    Anesth Analg; 2006 Jul; 103(1):49-51. PubMed ID: 16790624
    [No Abstract]   [Full Text] [Related]  

  • 12. Charging for investigational drugs under an investigational new drug application. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Aug; 74(155):40871-900. PubMed ID: 19691172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drug approval times and clinical evidence in Japan.
    Ono S; Yoshioka C; Asaka O; Tamura K; Shibata T; Saito K
    Contemp Clin Trials; 2005 Dec; 26(6):660-72. PubMed ID: 16122988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Review process of anticancer drugs in Japan].
    Hori A
    Rinsho Ketsueki; 2006 Jul; 47(7):626-32. PubMed ID: 16910572
    [No Abstract]   [Full Text] [Related]  

  • 15. Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: impact of FDA pharmacometrics during 2004-2006.
    Wang Y; Bhattaram AV; Jadhav PR; Lesko LJ; Madabushi R; Powell JR; Qiu W; Sun H; Yim DS; Zheng JJ; Gobburu JV
    J Clin Pharmacol; 2008 Feb; 48(2):146-56. PubMed ID: 18199891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent progress of clinical trials in urologic oncology].
    Hinotsu S
    Gan To Kagaku Ryoho; 2006 Feb; 33(2):188-92. PubMed ID: 16484854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical issues and observations on the use of foreign clinical data in drug development.
    Goto M; Hamasaki T
    J Biopharm Stat; 2002 Aug; 12(3):369-84. PubMed ID: 12448578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delays in psychiatric drug development in Japan.
    Shimazawa R; Kusumi I; Ikeda M
    J Clin Pharm Ther; 2012 Jun; 37(3):348-51. PubMed ID: 22017294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current good manufacturing practice and investigational new drugs intended for use in clinical trials. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Jul; 73(136):40453-63. PubMed ID: 18850678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New clinical trials policy at FDA.
    Vastag B
    Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.